Volume 27, Issue 3, October 2019, Pages 793–796
F. Abdeddine1, J. Meddah2, Mounia El Youssfi3, M.A. BENYAHIA4, and Samir Bargach5
1 Service de gynécologie obstétrique cancérologie et grossesse à haut risque, Maternité Souissi, Université Mohamed V, Rabat, Morocco
2 Service de gynécologie obstétrique cancérologie et grossesse à haut risque, Maternité Souissi, Université Mohamed V, Rabat, Morocco
3 Service de gynécologie obstétrique cancérologie et grossesse à haut risque, maternité Souissi, Université Mohamed V, Rabat, Morocco
4 Service de gynécologie obstétrique cancérologie et grossesse à haut risque, Maternité Souissi, Université Mohamed V, Rabat, Morocco
5 Department of Gynecology-Obstetrics-Oncology and High-Risk Pregnancy, Souissi Maternity Hospital, Ibn Sina University Hospital Center, Rabat, Morocco
Original language: English
Copyright © 2019 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The Ovarian Carcinosarcoma also known as malignant mixed Müllerian tumor is a rare malignant neoplasm that histologically contain both epithelial and stromal components. This aggressive tumor is found not only in the ovary but also in other organs of the genito-urinary tract, including uterus. It is usually diagnosed at older age and advanced stage. The Ovarian Carcinosarcoma patients have very poor prognosis. Surgical treatment is a determining factor for the survival of patients. The response rate to chemotherapy is about 20 %. We illustrate the article with a clinical case reporting the positive diagnosis of ovarian carcinosarcoma.
Author Keywords: Ovarian Carcinosarcoma, malignant tumor, epithelial, stromal, poor prognosis.
F. Abdeddine1, J. Meddah2, Mounia El Youssfi3, M.A. BENYAHIA4, and Samir Bargach5
1 Service de gynécologie obstétrique cancérologie et grossesse à haut risque, Maternité Souissi, Université Mohamed V, Rabat, Morocco
2 Service de gynécologie obstétrique cancérologie et grossesse à haut risque, Maternité Souissi, Université Mohamed V, Rabat, Morocco
3 Service de gynécologie obstétrique cancérologie et grossesse à haut risque, maternité Souissi, Université Mohamed V, Rabat, Morocco
4 Service de gynécologie obstétrique cancérologie et grossesse à haut risque, Maternité Souissi, Université Mohamed V, Rabat, Morocco
5 Department of Gynecology-Obstetrics-Oncology and High-Risk Pregnancy, Souissi Maternity Hospital, Ibn Sina University Hospital Center, Rabat, Morocco
Original language: English
Copyright © 2019 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
The Ovarian Carcinosarcoma also known as malignant mixed Müllerian tumor is a rare malignant neoplasm that histologically contain both epithelial and stromal components. This aggressive tumor is found not only in the ovary but also in other organs of the genito-urinary tract, including uterus. It is usually diagnosed at older age and advanced stage. The Ovarian Carcinosarcoma patients have very poor prognosis. Surgical treatment is a determining factor for the survival of patients. The response rate to chemotherapy is about 20 %. We illustrate the article with a clinical case reporting the positive diagnosis of ovarian carcinosarcoma.
Author Keywords: Ovarian Carcinosarcoma, malignant tumor, epithelial, stromal, poor prognosis.
How to Cite this Article
F. Abdeddine, J. Meddah, Mounia El Youssfi, M.A. BENYAHIA, and Samir Bargach, “Ovarian Carcinosarcoma : A case report and review of literature,” International Journal of Innovation and Applied Studies, vol. 27, no. 3, pp. 793–796, October 2019.
